Why the study?
The cardioprotective effects of GLP-1R agonists against methylglyoxal-induced oxidative stress and mitochondrial abnormalities, along with the underlying signaling pathways, have not been elucidated.
Does GLP-1R stimulation with exendin-4 inhibit methylglyoxal-induced mitochondrial dysfunction and oxidative stress in H9c2 cardiomyoblasts?
Does GLP-1R stimulation with exendin-4 inhibit methylglyoxal-induced mitochondrial dysfunction and oxidative stress in H9c2 cardiomyoblasts?
Answers are grounded in this paper and cite their sources.
GLP-1R stimulation with exendin-4 protects H9c2 cardiomyoblasts against methylglyoxal-induced mitochondrial dysfunction and oxidative stress via the cAMP/Epac/PI3K/Akt pathway.
Accumulation of methylglyoxal (MG) contributes to oxidative stress, apoptosis, and mitochondrial dysfunction, leading to the development of type 2 diabetes and cardiovascular diseases. Inhibition of mitochondrial abnormalities induced by MG in the heart may improve and delay the progression of heart failure. Although glucagon-like peptide-1 receptor (GLP-1R) agonists have been used as anti-diabetic drugs and GLP-1R has been detected in the heart, the cardioprotective effects of GLP-1R agonists on the inhibition of MG-induced oxidative stress and mitochondrial abnormalities have not been elucidated. Stimulation of GLP-1Rs leads to cAMP elevation and subsequently activates PKA- and/or Epac-dependent signaling pathway. However, the signaling pathway involved in the prevention of MG-induced mitochondrial dysfunctions in the heart has not been clarified so far. In the present study, we demonstrated that stimulation of GLP-1Rs with exendin-4 inhibited MG-induced intracellular and mitochondrial reactive oxygen species (ROS) production and apoptosis in H9c2 cardiomyoblasts. GLP-1R stimulation also improved the alterations of mitochondrial membrane potential (MMP) and expressions of genes related to mitochondrial functions and dynamics induced by MG. In addition, stimulation of GLP-1R exhibits antioxidant and antiapoptotic effects as well as the improvement of mitochondrial functions through cAMP/Epac/PI3K/Akt signaling pathway in H9c2 cells. Our study is the first work demonstrating a novel signaling pathway for cardioprotective effects of GLP-1R agonist on inhibition of oxidative stress and prevention of mitochondrial dysfunction. Thus, GLP-1R agonist represents a potential therapeutic target for inhibition of oxidative stress and modulation of mitochondrial functions in the heart.
No takes yet. Share an insight, caveat, or question.
Nuamnaichati et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: